Abdominal aortic aneurysm (AAA) occurs when atherosclerosis or plaque buildup causes the walls of the abdominal aorta to become weak and bulge outward like a balloon. An AAA develops slowly over time and has few noticeable symptoms. The larger an aneurysm grows, the more likely it will burst or rupture, causing intense abdominal or back pain, dizziness, nausea or shortness of breath. Most people with an abdominal aortic aneurysm do not have any symptoms. Often, the aneurysm grows slowly and goes unnoticed.
Major risk factors for an Abdominal Aortic Aneurysm include family history, smoking, and long-standing high blood pressure. According to the Centers for Disease Control and Prevention (CDC), men who have a history of smoking should receive a one-time screening for triple-A between the ages of 65 and 75. Men with a family history of AAA should be screened at age 60.
Get FREE sample copy at:
The Abdominal Aortic Aneurysm market report also covers emerging drugs, current treatment practices, Abdominal Aortic Aneurysm market share of the individual therapies, current and forecasted Abdominal Aortic Aneurysm Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Abdominal Aortic Aneurysm treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Abdominal Aortic Aneurysm Market Key Facts
As per the study conducted by Palma M. Shaw et al. (2019), the prevalence of abdominal aortic aneurysms increases after age 60, and it peaks in the seventh and eighth decades of life.
- Data derived from Lifeline AAA screening and National Health and Nutrition Examination Survey (NHANES, 2003-2006) database reveals a prevalence of 1.4% or 1.1 million AAAs in those studied aged 50–84.
As per the study conducted by Melba W.G. Swafford et al. (2007), Abdominal aortic aneurysms, the 13th leading cause of death in the United States, are most commonly due to degeneration from arteriosclerosis. They comprise 65% of all aortic aneurysms; 90% occur below the renal arteries.
As per the study conducted by Beverly L. Harger et al. (2014), Abdominal aortic aneurysm (AAA) affects approximately 2% to 8% of the population older than 60 years. The prevalence increases rapidly in men after age 55 years and in women after age 70 years.
Key Benefits of Abdominal Aortic Aneurysm Market Report
Abdominal Aortic Aneurysm market report provides an in-depth analysis of Abdominal Aortic Aneurysm Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.
The Abdominal Aortic Aneurysm market report will help in developing business strategies by understanding the Abdominal Aortic Aneurysm Market trends & developments, key players, and future market competition that will shape and drive the Abdominal Aortic Aneurysm market in the upcoming years.
The Abdominal Aortic Aneurysm market report covers Abdominal Aortic Aneurysm current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
The report provides a detailed assessment of the Abdominal Aortic Aneurysm market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Abdominal Aortic Aneurysm market size is expected to increase during the forecast period owing to the rise in the number of prevalent cases of Abdominal Aortic Aneurysm patients in 7MM. Extensive research and development activities of pharmaceutical companies for developing the therapies for Abdominal Aortic Aneurysm will also significantly impact the market during the forecast period.
The Abdominal Aortic Aneurysm market outlook section of the report helps to build a detailed comprehension of the historic, current and forecasted Abdominal Aortic Aneurysm market trends by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.
The report gives a thorough detail of the Abdominal Aortic Aneurysm market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Abdominal Aortic Aneurysm Epidemiology
The Abdominal Aortic Aneurysm epidemiology section covers insights about the historical and current Abdominal Aortic Aneurysm patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Abdominal Aortic Aneurysm Drugs Uptake and Key Market Players
The Abdominal Aortic Aneurysm Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Abdominal Aortic Aneurysm market or expected to get launched in the market during the study period. The analysis covers Abdominal Aortic Aneurysm market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The current pipeline for Abdominal Aortic Aneurysm has many significant products which are being developed by key players. Some of the prominent players in the Abdominal Aortic Aneurysm market include Merck Serono, AstraZeneca, and many others.
Abdominal Aortic Aneurysm therapies covered in the report include Glucophage, Ticagrelor, and many more.
Additionally, several companies, such as Boston Scientific Corporation (TriVascular Stent-Graft System), Bolton Medical (Treovance stent-graft), Cordis Corporation (Cordis AAA stent graft system), TriVascular (TriVascular Ovation Abdominal Stent Graft System) are also developing medical devices for the treatment of Abdominal Aortic Aneurysm.
Table of Content
1. Key Insights
2. Executive Summary
3. Abdominal Aortic Aneurysm Competitive Intelligence Analysis
4. Abdominal Aortic Aneurysm Market Overview at a Glance
5. Abdominal Aortic Aneurysm Disease Background and Overview
6. Abdominal Aortic Aneurysm Patient Journey
7. Abdominal Aortic Aneurysm Epidemiology and Patient Population
8. Abdominal Aortic Aneurysm Treatment Algorithm, Current Treatment, and Medical Practices
9. Abdominal Aortic Aneurysm Unmet Needs
10. Key Endpoints of Abdominal Aortic Aneurysm Treatment
11. Abdominal Aortic Aneurysm Marketed Products
12. Abdominal Aortic Aneurysm Emerging Therapies
13. Abdominal Aortic Aneurysm Seven Major Market Analysis
14. Attribute Analysis
15. Abdominal Aortic Aneurysm Market Outlook (7 major markets)
16. Abdominal Aortic Aneurysm Access and Reimbursement Overview
17. KOL Views on the Abdominal Aortic Aneurysm Market.
18. Abdominal Aortic Aneurysm Market Drivers
19. Abdominal Aortic Aneurysm Market Barriers
21. DelveInsight Capabilities
*The table of contents is not exhaustive; the final content may vary.
Abdominal Aortic Aneurysm Pipeline Insights
Abdominal Aortic Aneurysm Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Abdominal Aortic Aneurysm market.
BioPharma Blog – Medical Tourism Market Overview
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd. 2432
City: Las Vegas
Country: United States